Literature DB >> 17171533

Exacerbation of sickle cell disease itself as a cause of abnormal liver chemistry tests.

Carmen M Stanca1, Maria Isabel Fiel, Thomas D Schiano.   

Abstract

Liver pathology occurring in patients with sickle cell disease is commonly related to viral hepatitis or hepatic iron deposition due to repeated transfusions; cholestasis and cirrhosis may also occur. Consequently, the differential diagnosis of abnormal liver tests in patients with sickle cell anemia is often complicated. We report the case of a patient presenting with jaundice and abnormal liver biochemistries, without typical evidence of the liver diseases associated with sickle cell anemia. Biochemical markers for viral hepatitis were negative. CT scan only showed hepatomegaly. The liver biopsy revealed marked sinusoidal congestion with red blood cells without significant steatosis or increased iron deposition. The patient's medical history corroborated with biochemical tests and histological examination of the liver suggested that worsening hemolysis related to increased sickling of erythrocytes intrahepatically led to sinusoidal dilatation and probably caused the abnormal liver tests.

Entities:  

Mesh:

Year:  2006        PMID: 17171533     DOI: 10.1007/s10620-006-9368-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  18 in total

Review 1.  Sickle cell hepatopathy.

Authors:  S Banerjee; C Owen; S Chopra
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

2.  Letter: sickle cell trait in the nonblack population.

Authors:  C J McGrew
Journal:  JAMA       Date:  1975-06-30       Impact factor: 56.272

3.  Frequency of sickling disorders in U.S. blacks.

Authors:  A G Motulsky
Journal:  N Engl J Med       Date:  1973-01-04       Impact factor: 91.245

4.  Hepatobiliary changes in Nigerians with sickle cell anaemia.

Authors:  Y A Aken'ova; B J Olasode; J O Ogunbiyi; J O Thomas
Journal:  Ann Trop Med Parasitol       Date:  1993-12

5.  Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy.

Authors:  P Harmatz; E Butensky; K Quirolo; R Williams; L Ferrell; T Moyer; D Golden; L Neumayr; E Vichinsky
Journal:  Blood       Date:  2000-07-01       Impact factor: 22.113

6.  Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.

Authors:  Ersi Voskaridou; Maroussa Douskou; Evangelos Terpos; Ioannis Papassotiriou; Alexandra Stamoulakatou; Akis Ourailidis; Aphroditi Loutradi; Dimitris Loukopoulos
Journal:  Br J Haematol       Date:  2004-09       Impact factor: 6.998

7.  The liver in sickle cell disease. A clinicopathologic study of 70 patients.

Authors:  T W Bauer; G W Moore; G M Hutchins
Journal:  Am J Med       Date:  1980-12       Impact factor: 4.965

8.  Pathological spectrum of liver diseases in sickle cell disease.

Authors:  M Omata; C S Johnson; M Tong; D Tatter
Journal:  Dig Dis Sci       Date:  1986-03       Impact factor: 3.199

9.  Abdominal pain in sickle cell disease: the role of CT.

Authors:  D Magid; E K Fishman; S Charache; S S Siegelman
Journal:  Radiology       Date:  1987-05       Impact factor: 11.105

10.  Transfusion and exchange transfusion in sickle cell anaemias, with particular reference to iron metabolism.

Authors:  J B Porter; E R Huehns
Journal:  Acta Haematol       Date:  1987       Impact factor: 2.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.